Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.

This article and associated images are based on a poster originally authored by Rebecca L. Rich, Anthony M. Giannetti, John Rosenfeld, Adam Shutes and Yusuke Kawase and presented at ELRIG Drug ...

Lutz Tautz, PhD, is a research associate professor in the Cancer Metabolism and Microenvironment Program at Sanford Burnham Prebys and senior and corresponding author of the study. The immune system ...